These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38811083)

  • 41. Amyloidosis.
    Sipe JD
    Crit Rev Clin Lab Sci; 1994; 31(4):325-54. PubMed ID: 7888076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Classification of amyloidosis].
    Misumi Y; Ando Y
    Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin.
    Almeida MR; Saraiva MJ
    FEBS Lett; 2012 Aug; 586(18):2891-6. PubMed ID: 22819819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The classification of amyloid deposits in clinicopathological practice.
    Röcken C; Schwotzer EB; Linke RP; Saeger W
    Histopathology; 1996 Oct; 29(4):325-35. PubMed ID: 8910040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a "protein misfolding disease".
    De Lorenzi E; Giorgetti S; Grossi S; Merlini G; Caccialanza G; Bellotti V
    Curr Med Chem; 2004 Apr; 11(8):1065-84. PubMed ID: 15078166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.
    Wall JS; Williams AD; Foster JS; Richey T; Stuckey A; Macy S; Wooliver C; Campagna SR; Tague ED; Farmer AT; Lands RH; Martin EB; Heidel RE; Kennel SJ
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10839-E10848. PubMed ID: 30377267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
    Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
    J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amyloidosis.
    Tan SY; Pepys MB
    Histopathology; 1994 Nov; 25(5):403-14. PubMed ID: 7868080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis.
    Zaky ZS; Liepnieks JJ; Rex DK; Cummings OW; Benson MD
    Amyloid; 2007 Dec; 14(4):299-304. PubMed ID: 17968691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteo-articular manifestations of amyloidosis.
    M'bappé P; Grateau G
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):459-75. PubMed ID: 23040361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Localized oral amyloidosis: ultrastructural and immunohistochemical study.
    Takeda Y; Sekiyama S; Suzuki A; Hirose H
    J Oral Pathol; 1987 May; 16(5):278-81. PubMed ID: 3116188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amyloidosis: new strategies for treatment.
    Hirschfield GM; Hawkins PN
    Int J Biochem Cell Biol; 2003 Dec; 35(12):1608-13. PubMed ID: 12962700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
    Sipe JD; Benson MD; Buxbaum JN; Ikeda SI; Merlini G; Saraiva MJ; Westermark P
    Amyloid; 2016 Dec; 23(4):209-213. PubMed ID: 27884064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel pharmacological strategies in amyloidosis.
    Lachmann HJ; Hawkins PN
    Nephron Clin Pract; 2003; 94(4):c85-8. PubMed ID: 12972717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
    Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
    Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein amyloidose misfolding: mechanisms, detection, and pathological implications.
    Jeyashekar NS; Sadana A; Vo-Dinh T
    Methods Mol Biol; 2005; 300():417-35. PubMed ID: 15657495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amyloidosis-inducing activity of blood cells in mouse AApoAII amyloidosis.
    Ding X; Liu Y; Yang M; Li L; Miyahara H; Dai J; Xu Z; Matsumoto K; Mori M; Higuchi K; Sawashita J
    Exp Anim; 2018 May; 67(2):105-115. PubMed ID: 29081441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Amyloidosis and hepatic amyloidosis].
    Murakami T; Yi S
    Nihon Rinsho; 1993 Feb; 51(2):453-7. PubMed ID: 8464159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.